Research & Development
Luminex passes FDA EUA for NxTAG CoV extended panel to detect the SARS-CoV-2 under BARDA award
30 March 2020 - Clinical diagnostics company Luminex Corporation (NASDAQ:LMNX) revealed on Friday the receipt of Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its high-throu...
Abbott introduces fast molecular point-of-care test to detect COVID-19
30 March 2020 - Healthcare company Abbott (NYSE:ABT) reported on Friday the receipt of US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for a fast molecular point-of-care test f...
Ryvu Therapeutics wins FDA orphan drug designation for SEL120 to treat acute myeloid leukemia
30 March 2020 - Biopharmaceutical company Ryvu Therapeutics (WSE:RVU) reported on Saturday the receipt of US Food and Drug Administration (FDA) orphan drug designation (ODD) to advance SEL120 to addre...
US FDA grants Orphan Drug Designation to PR Applied Pharma Research's APR-OD031
27 March 2020 - The United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Switzerland-based APR Applied Pharma Research SA's drug candidate, APR-OD031, intended ...
Thermo Fisher wins CE Mark for diagnostic test to detect COVID-19 across the EU; provides update on other designated approvals
27 March 2020 - Science products and services provider Thermo Fisher Scientific Inc (NYSE:TMO) revealed on Thursday that it has received the CE mark in the European Union for its diagnostic test to de...
Relief Therapeutics partners with NeuroRx to file IND for phase 2 trial of RLF-100 for COVID-19
27 March 2020 - Swiss drug development company Relief Therapeutics Holding AG (SIX:RLF) and NeuroRx, a Delaware Corporation, said on Thursday that they have jointly submitted an Investigational New Dr...